All Stories

  1. Existence and significance of viral nonreplicative RNA recombination
  2. Non-Canonical Translation Initiation Mechanisms Employed by Eukaryotic Viral mRNAs
  3. The Baltimore Classification of Viruses 50 Years Later: How Does It Stand in the Light of Virus Evolution?
  4. Polio eradication at the crossroads
  5. In pursuit of intriguing puzzles
  6. Characterization of Mutational Tolerance of a Viral RNA–Protein Interaction
  7. Emergency Services of Viral RNAs: Repair and Remodeling
  8. Pressure for Pattern-Specific Intertypic Recombination between Sabin Polioviruses: Evolutionary Implications
  9. A Cluster of Paralytic Poliomyelitis Cases Due to Transmission of Slightly Diverged Sabin 2 Vaccine Poliovirus
  10. Mutational robustness and resilience of a replicative cis-element of RNA virus: Promiscuity, limitations, relevance
  11. Attachment and Invasion of the Respiratory Tract
  12. Picornavirus Genetics: an Overview
  13. Picornavirus Genome: an Overview
  14. Cytopathic effects: virus-modulated manifestations of innate immunity?
  15. Viral security proteins: counteracting host defences
  16. Immunisation against poliomyelitis: moving forward
  17. Vaccination against polio should not be stopped
  18. Significance of the C-terminal amino acid residue in mengovirus RNA-dependent RNA polymerase
  19. Vaccine-derived polioviruses
  20. Don't drop current vaccine until we have new ones
  21. Variability in apoptotic response to poliovirus infection
  22. Apoptosis-related fragmentation, translocation, and properties of human prothymosin alpha
  23. Long-Term Circulation of Vaccine-Derived Poliovirus That Causes Paralytic Disease
  24. Early Alteration of Nucleocytoplasmic Traffic Induced by Some RNA Viruses
  25. Cross-talk between orientation-dependent recognition determinants of a complex control RNA element, the enterovirus oriR
  26. Prothymosin α fragmentation in apoptosis
  27. Paradoxes of the replication of picornaviral genomes
  28. Two Types of Death of Poliovirus-Infected Cells: Caspase Involvement in the Apoptosis but Not Cytopathic Effect
  29. Recombination and Other Genomic Rearrangements in Picornaviruses
  30. Final checkpoint in the drug-promoted and poliovirus-promoted apoptosis is under post-translational control by growth factors
  31. Final checkpoint in the drug‐promoted and poliovirus‐promoted apoptosis is under post‐translational control by growth factors
  32. Poliovirus Neurovirulence Correlates with the Presence of a Cryptic AUG Upstream of the Initiator Codon
  33. Modification of translational control elements as a new approach to design of attenuated picornavirus strains
  34. A model for rearrangements in RNA genomes
  35. Starting Window, a Distinct Element in the Cap-independent Internal Initiation of Translation on Picornaviral RNA
  36. Genetic studies on the poliovirus 2C protein, an NTPase A plausible mechanism of guanidine effect on the 2C function and evidence for the importance of 2C oligomerization
  37. Russian Contribution to OPV
  38. Poliovirus Neurovirulence and its Attenuation
  39. Towards identification ofcis-acting elements involved in the replication of enterovirus and rhinovirus RNAs: a proposal for the existence of tRNA-like terminal structures
  40. Prokaryotic-like cis elements in the cap-independent internal initiation of translation on picornavirus RNA
  41. Coupled mutations in the 5'-untranslated region of the Sabin poliovirus strains during in vivo passages: structural and functional implications
  42. The 5′-Untranslated Region of Picornaviral Genomes
  43. Gross rearrangements within the 5′-untranslated region of the picornaviral genomes
  44. Distinct modes of poliovirus polyprotein initiation in vitro
  45. Conserved structural domains in the 5′-untranslated region of picornaviral genomes: An analysis of the segment controlling translation and neurovirulence
  46. Point mutations modify the response of poliovirus RNA to a translation initiation factor: A comparison of neurovirulent and attenuated strains
  47. Small cytoplasmic RNA from mouse cells covalently linked to a protein
  48. Studies on the recombination between RNA genomes of poliovirus: The primary structure and nonrandom distribution of crossover regions in the genomes of intertypic poliovirus recombinants
  49. The primary structure of crossover regions of intertypic poliovirus recombinants: A model of recombination between RNA genomes
  50. The Genomes of attenuated and virulent poliovirus strains differ in their in vitro translation efficiencies
  51. Encephalomyocarditis virus replication complexes preferentially utilizing nucleoside diphosphates as substrates for viral RNA synthesis. Nucleotide kinases specifically associated with the complex channel RNA precursor
  52. Differences between translation products of tick-borne encephalitis virus RNA in cell-free systems from Krebs-2 cells and rabbit reticulocytes: Involvement of membranes in the processing of nascent precursors of flavivirus structural proteins
  53. Encephalomyocarditis virus replication complexes that Prefer nucleoside diphosphates as substrates for viral RNA synthesis
  54. Translational Barrier in Central Region of Encephalomyocarditis Virus Genome. Modulation by Elongation Factor 2 (eEF-2)
  55. Intertypic recombination in poliovirus: Genetic and biochemical studies
  56. An RNA-Dependent Nucleoside Triphosphate Hydrolase from Krebs-II Ascites Tumor Cells. Detection and Preliminary Characterization
  57. Towards the system of viruses
  58. Efficiency of Translation of Viral and Cellular mRNA’s in Extracts from Cells Infected with Encephalomyocarditis Virus
  59. Picornaviruses as a Model for Studying the Nature of RNA Recombination
  60. The Origin and Evolution of Viruses